DE:7JK Stock Latest News
Company AnnouncementsEQL Pharma to Present Q2 2026/27 Interim Report in Investor Webcast4d ago
Company AnnouncementsEQL Pharma AGM Confirms Board, Withholds Dividend and Launches New Incentive Plan2M ago
Company AnnouncementsEQL Pharma Licenses UTI Drug Memprex to Pharmacenter in Hungary2M ago- Company AnnouncementsEQL Pharma Hit by Write-Downs and Delays but Holds 15% Sales Growth Outlook2M ago
Pre-EarningsIs 7JK a Buy, Before Earnings?2M ago
Company AnnouncementsEQL Pharma hires new Chief Supply Chain Officer to support next growth phase3M ago
Company AnnouncementsEQL Pharma’s Mellozzan Wins Approval in Kazakhstan, Extending Niche Generics Reach3M ago
Company AnnouncementsEQL Pharma Licenses UTI Drug Memprex to Gebro for Spanish Market3M ago
Company AnnouncementsEQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation3M ago- Company AnnouncementsEQL Pharma’s Cystohipp Launch Opens New UTI Market in Germany4M ago
Company AnnouncementsEQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline5M ago
Pre-Earnings7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?6M agoCompany AnnouncementsEQL Pharma Seeks New Supply Chain Chief to Bolster Niche Generics Strategy6M ago
Company AnnouncementsEQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption7M ago- Company AnnouncementsEQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan7M ago
Company AnnouncementsEQL Pharma Names Nomination Committee Ahead of 2026 AGM8M ago
Company AnnouncementsEQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees9M ago
Company AnnouncementsEQL Pharma Posts Record Quarter as European Expansion and Pipeline Drive Growth9M ago